Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only.
- Positions
- 5
- No filing for Q3 2024
- Portfolio value
- $139.2M
- No filing for Q3 2024
Enavate Sciences GP, LLC did not file a 13F for Q3 2024, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UPBUpstream Bio, Inc. | COM | 2,459,703 | $40.4M | 29.0% | – | – | History |
| IMNMImmunome Inc. | COM | 3,478,261 | $36.9M | 26.5% | – | – | History |
| ZBIOZenas BioPharma, Inc. | COM | 3,761,359 | $30.8M | 22.1% | – | – | History |
| CAMPCamp4 Therapeutics Corp | COM | 3,785,802 | $19.8M | 14.2% | – | – | History |
| CMPXCompass Therapeutics, Inc. | COM | 7,788,150 | $11.3M | 8.1% | – | – | History |